The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISTH 2022 | Measuring whole blood thrombin generation in patients with multiple myeloma
Joke Konings, PhD, Synapse Research Institute, Maastricht, The Netherlands, discusses the main aims and results of a study investigating the prevalence of acquired platelet secretion and blood thrombin generation in patients with multiple myeloma and future implications of this research for the treatment of thrombosis in these patients. Dr Konings This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.
